Eiko Imamoto

450 total citations
18 papers, 320 citations indexed

About

Eiko Imamoto is a scholar working on Surgery, Molecular Biology and Gastroenterology. According to data from OpenAlex, Eiko Imamoto has authored 18 papers receiving a total of 320 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Surgery, 7 papers in Molecular Biology and 5 papers in Gastroenterology. Recurrent topics in Eiko Imamoto's work include Gastroesophageal reflux and treatments (4 papers), Helicobacter pylori-related gastroenterology studies (4 papers) and Eosinophilic Esophagitis (3 papers). Eiko Imamoto is often cited by papers focused on Gastroesophageal reflux and treatments (4 papers), Helicobacter pylori-related gastroenterology studies (4 papers) and Eosinophilic Esophagitis (3 papers). Eiko Imamoto collaborates with scholars based in Japan, France and United States. Eiko Imamoto's co-authors include Yuji Naito, Satoshi Kokura, Toshikazu Yoshikawa, Norimasa Yoshida, Kazuhiko Uchiyama, Tomohisa Takagi, Osamu Handa, Hiroshi Ichikawa, Takeshi Okanoue and Naoya Tomatsuri and has published in prestigious journals such as Gastroenterology, Cancer Letters and Alimentary Pharmacology & Therapeutics.

In The Last Decade

Eiko Imamoto

18 papers receiving 317 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eiko Imamoto Japan 12 129 118 58 40 38 18 320
H. Suetsugu Japan 6 203 1.6× 111 0.9× 24 0.4× 18 0.5× 56 1.5× 7 389
Ryoji Yoshinaka Japan 9 122 0.9× 87 0.7× 35 0.6× 14 0.3× 54 1.4× 9 360
Anne-Laure Sberna France 7 107 0.8× 116 1.0× 75 1.3× 34 0.8× 6 0.2× 8 484
Guanqun Xie China 12 130 1.0× 31 0.3× 89 1.5× 31 0.8× 28 0.7× 27 356
Zhifeng Zhang China 10 106 0.8× 103 0.9× 18 0.3× 13 0.3× 80 2.1× 13 321
Lingdan Chen China 9 109 0.8× 44 0.4× 48 0.8× 18 0.5× 16 0.4× 15 255
Nobuhito Taniki Japan 14 131 1.0× 62 0.5× 137 2.4× 52 1.3× 12 0.3× 43 589
S. Vaja United Kingdom 13 117 0.9× 131 1.1× 26 0.4× 23 0.6× 38 1.0× 33 376
Xiaojian Wu China 7 155 1.2× 45 0.4× 22 0.4× 24 0.6× 27 0.7× 27 301
Sing Shang Ngoi Singapore 9 68 0.5× 171 1.4× 18 0.3× 26 0.7× 10 0.3× 12 384

Countries citing papers authored by Eiko Imamoto

Since Specialization
Citations

This map shows the geographic impact of Eiko Imamoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eiko Imamoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eiko Imamoto more than expected).

Fields of papers citing papers by Eiko Imamoto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eiko Imamoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eiko Imamoto. The network helps show where Eiko Imamoto may publish in the future.

Co-authorship network of co-authors of Eiko Imamoto

This figure shows the co-authorship network connecting the top 25 collaborators of Eiko Imamoto. A scholar is included among the top collaborators of Eiko Imamoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eiko Imamoto. Eiko Imamoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Uchiyama, Kazuhiko, et al.. (2024). Correlation of gastrointestinal symptom rating scale and frequency scale for the symptoms of gastroesophageal reflux disease with endoscopic findings. Scandinavian Journal of Gastroenterology. 59(11). 1220–1228. 1 indexed citations
2.
Handa, Osamu, et al.. (2020). Helicobacter pylori eradication therapy outcome according to clarithromycin susceptibility testing in Japan. Helicobacter. 25(4). e12698–e12698. 22 indexed citations
3.
Ando, Takashi, Takeshi Ishikawa, Eiko Imamoto, et al.. (2012). A Case of Inoperable Duodenal Cancer Achieving Long-Term Survival after Multidisciplinary Treatment. Case Reports in Gastroenterology. 6(1). 111–117. 3 indexed citations
4.
Ando, Takashi, Takeshi Ishikawa, Tomohisa Takagi, et al.. (2012). Impact of Helicobacter pylori Eradication on Circulating Adiponectin in Humans. Helicobacter. 18(2). 158–164. 30 indexed citations
5.
Naito, Yuji, Nobuaki Yagi, Eiko Imamoto, et al.. (2008). Prevention of Indomethacin-Induced Gastric Mucosal Injury in Helicobacter pylori-Negative Healthy Volunteers: A Comparison Study Rebamipide vs Famotidine. Journal of Clinical Biochemistry and Nutrition. 43(1). 34–40. 24 indexed citations
6.
Ishikawa, Takeshi, Takashi Ando, Eiko Imamoto, et al.. (2007). [Effect of clinical pathway in the treatment of inpatients with ischemic colitis].. PubMed. 104(3). 357–63. 1 indexed citations
7.
Yoshida, N., Eiko Imamoto, Kazuhiko Uchiyama, et al.. (2006). Molecular mechanisms involved in interleukin‐8 production by normal human oesophageal epithelial cells. 2(1). 219–226. 12 indexed citations
8.
Yoshida, N., Eiko Imamoto, Kazuhiko Uchiyama, et al.. (2006). Molecular mechanisms involved in interleukin‐8 production by normal human oesophageal epithelial cells. Alimentary Pharmacology & Therapeutics. 24(s4). 219–226. 12 indexed citations
9.
Higashihara, Hiroshi, Satoshi Kokura, Eiko Imamoto, et al.. (2004). Hypoxia–reoxygenation enhances interleukin-8 production from U937 human monocytic cells. Redox Report. 9(6). 365–369. 3 indexed citations
10.
Imamoto, Eiko, Norimasa Yoshida, Kazuhiko Uchiyama, et al.. (2004). Inhibitory effect of pioglitazone on expression of adhesion molecules on neutrophils and endothelial cells. BioFactors. 20(1). 37–47. 47 indexed citations
11.
Kokura, Satoshi, Norimasa Yoshida, Eiko Imamoto, et al.. (2004). Anoxia/reoxygenation down-regulates the expression of E-cadherin in human colon cancer cell lines. Cancer Letters. 211(1). 79–87. 16 indexed citations
12.
Tomatsuri, Naoya, Norimasa Yoshida, Tomohisa Takagi, et al.. (2004). Edaravone, a newly developed radical scavenger, protects against ischemia-reperfusion injury of the small intestine in rats. International Journal of Molecular Medicine. 13(1). 105–9. 40 indexed citations
13.
Kokura, Satoshi, Norimasa Yoshida, Eiko Imamoto, et al.. (2003). Hyperthermia enhances tumor necrosis factor α-induced apoptosis of a human gastric cancer cell line. Cancer Letters. 201(1). 89–96. 21 indexed citations
14.
Kokura, Satoshi, Eiko Imamoto, Yuji Naito, et al.. (2003). Blocking of NF-κB activation enhances the tumor necrosis factor α-induced apoptosis of a human gastric cancer cell line. Cancer Letters. 193(2). 177–182. 15 indexed citations
15.
Imamoto, Eiko, Norimasa Yoshida, Kazuhiko Uchiyama, et al.. (2003). Effects of bile acids and acidic exposure on IL-8 expression in human esophageal epithelial cells. Gastroenterology. 124(4). A409–A409. 4 indexed citations
16.
Isozaki, Yutaka, Norimasa Yoshida, Kazuhiro Katada, et al.. (2003). Edaravone, a newly developed radical scavenger, protects against ischemia-reperfusion injury of the small intestine in rats. Gastroenterology. 124(4). A150–A150. 2 indexed citations
17.
Naito, Yuji, Tomohisa Takagi, Kazuhiko Uchiyama, et al.. (2002). Suppression of intestinal ischemia-reperfusion injury by a specific peroxisome proliferator-activated receptor-γ ligand, pioglitazone, in rats. Redox Report. 7(5). 294–299. 52 indexed citations
18.
Naito, Yuji, Osamu Handa, Tomohisa Takagi, et al.. (2002). Ubiquitin‐proteasome inhibitor enhances tumour necrosis factor‐α‐induced apoptosis in rat gastric epithelial cells. Alimentary Pharmacology & Therapeutics. 16(s2). 59–66. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by H. Suetsugu Breakdown of academic impact, for papers by Ryoji Yoshinaka Breakdown of academic impact, for papers by Anne-Laure Sberna Breakdown of academic impact, for papers by Guanqun Xie Breakdown of academic impact, for papers by Zhifeng Zhang Breakdown of academic impact, for papers by Lingdan Chen Breakdown of academic impact, for papers by Nobuhito Taniki Breakdown of academic impact, for papers by S. Vaja Breakdown of academic impact, for papers by Xiaojian Wu Breakdown of academic impact, for papers by Sing Shang Ngoi
Rankless by CCL
2026